Emcure Pharmaceuticals Receives USFDA Form 483 With Seven Observations
Emcure Pharmaceuticals received a USFDA Form 483 with seven observations following a cGMP inspection at its Sanand manufacturing facility in Gujarat.
Could Hantavirus Become The Next Pandemic? Here’s What Experts Are Saying
Hantavirus infections can be severe, but experts say the virus spreads poorly between humans and is unlikely to trigger a COVID-like pandemic.
Alkem Laboratories Gets USFDA Form 483 With 7 Observations At Daman Facility
Alkem Laboratories faces USFDA scrutiny after receiving seven observations at its Daman plant, weeks after securing EU GMP certification.
Sun Pharma, Cipla Recall Products In US Following Manufacturing Lapses
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled multiple products from the US market after the regulator flagged manufacturing-related issues.
